Literature DB >> 28236967

The Hippo Pathway: A Master Regulatory Network Important in Development and Dysregulated in Disease.

Cathie M Pfleger1.   

Abstract

The Hippo Pathway is a master regulatory network that regulates proliferation, cell growth, stemness, differentiation, and cell death. Coordination of these processes by the Hippo Pathway throughout development and in mature organisms in response to diverse external and internal cues plays a role in morphogenesis, in controlling organ size, and in maintaining organ homeostasis. Given the importance of these processes, the Hippo Pathway also plays an important role in organismal health and has been implicated in a variety of diseases including eye disease, cardiovascular disease, neurodegeneration, and cancer. This review will focus on Drosophila reports that identified the core components of the Hippo Pathway revealing specific downstream biological outputs of this complicated network. A brief description of mammalian reports will complement review of the Drosophila studies. This review will also survey upstream regulation of the core components with a focus on feedback mechanisms.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hippo; Lats1/2; MST1/2; Mats; Oncogenes; Organ homeostasis; Sav; TAZ; Tumor suppressors; Warts; YAP; Yorkie

Mesh:

Year:  2017        PMID: 28236967     DOI: 10.1016/bs.ctdb.2016.12.001

Source DB:  PubMed          Journal:  Curr Top Dev Biol        ISSN: 0070-2153            Impact factor:   4.897


  32 in total

1.  Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2-Dependent Mechanism in Polycystic Kidney Disease.

Authors:  Nidhi Dwivedi; Shixin Tao; Abeda Jamadar; Sonali Sinha; Christianna Howard; Darren P Wallace; Timothy A Fields; Andrew Leask; James P Calvet; Reena Rao
Journal:  J Am Soc Nephrol       Date:  2020-06-17       Impact factor: 10.121

2.  Potential Value of YAP Staining in Rhabdomyosarcoma.

Authors:  Atif A Ahmed; Sultan S Habeebu; Ashley K Sherman; Shui Q Ye; Nicole Wood; Katherine M Chastain; Maria G Tsokos
Journal:  J Histochem Cytochem       Date:  2018-03-29       Impact factor: 2.479

3.  The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number.

Authors:  Alfonso Lavado; Jun Young Park; Joshua Paré; David Finkelstein; Haitao Pan; Beisi Xu; Yiping Fan; Ram Parikshan Kumar; Geoffrey Neale; Young Don Kwak; Peter J McKinnon; Randy L Johnson; Xinwei Cao
Journal:  Dev Cell       Date:  2018-10-25       Impact factor: 12.270

4.  Active epithelial Hippo signaling in idiopathic pulmonary fibrosis.

Authors:  Jason J Gokey; Anusha Sridharan; Yan Xu; Jenna Green; Gianni Carraro; Barry R Stripp; Anne-Karina T Perl; Jeffrey A Whitsett
Journal:  JCI Insight       Date:  2018-03-22

5.  The Hippo Pathway Effectors YAP and TAZ Regulate LH Release by Pituitary Gonadotrope Cells in Mice.

Authors:  Ariane Lalonde-Larue; Alexandre Boyer; Esdras Corrêa Dos Santos; Derek Boerboom; Daniel J Bernard; Gustavo Zamberlam
Journal:  Endocrinology       Date:  2022-01-01       Impact factor: 4.736

6.  YAP regulates alveolar epithelial cell differentiation and AGER via NFIB/KLF5/NKX2-1.

Authors:  Jason J Gokey; John Snowball; Anusha Sridharan; Parvathi Sudha; Joseph A Kitzmiller; Yan Xu; Jeffrey A Whitsett
Journal:  iScience       Date:  2021-08-11

7.  The clinicopathological and prognostic significances of LATS1 expression in breast cancer.

Authors:  Hua-Chuan Zheng; Li-Wei Xiang; Zheng-Guo Cui; Hang Xue; Ying E; Ming-Zhen Zhao
Journal:  Histol Histopathol       Date:  2022-02-10       Impact factor: 2.130

8.  Circular RNA circRPPH1 promotes triple-negative breast cancer progression via the miR-556-5p/YAP1 axis.

Authors:  Yehui Zhou; Xiaorong Liu; Jing Lan; Yuqiu Wan; Xun Zhu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

9.  Network Pharmacology-Based Mechanistic Investigation of Jinshui Huanxian Formula Acting on Idiopathic Pulmonary Fibrosis.

Authors:  Tiantian Liu; Pengli Xu; Shuishui Qi; Shaorui Ke; Qin Hu; Peng Zhao; Jiansheng Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-07       Impact factor: 2.629

10.  A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis.

Authors:  T Azad; H J Janse van Rensburg; E D Lightbody; B Neveu; A Champagne; A Ghaffari; V R Kay; Y Hao; H Shen; B Yeung; B A Croy; K L Guan; F Pouliot; J Zhang; C J B Nicol; X Yang
Journal:  Nat Commun       Date:  2018-03-13       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.